top
logo


Home Publicações Artigos
Artigos
title Filter     Exibir # 
# Título do Artigo
1 Carta do Secretário Geral da ONU a presidente Dilma sobre o Programa Nacional de Tuberculose
2 Efficacy and Safety of a 4-Drug Fixed-Dose Combination Regimen Compared With Separate Drugs for Treatment of Pulmonary Tuberculosis
3 WORLD TB DAY EDITORIAL: New tools for achieving TB control: progress and reflexion
4 A Dynamic Analysis of Tuberculosis Dissemination to Improve Control and Surveillance
5 Farmabrasilis - Scientific Papers
6 An emerging medicine to treat infectious diseases
7 Strengthening our natural defences: a new drug candidate and a new approach to fighting infectious diseases
8 Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country
9 Extensive transmission of isoniazid resistant M. tuberculosis and its association with increased multidrug-resistant TB in two rural counties of eastern China: A molecular epidemiological study
10 Multidrug-resistant TB: What NPs Need to Know
11 Results of directly observed treatment for tuberculosis in Ensenada, Mexico: not all DOTS programs are created equally
12 The mycobacterium bovis BCG phagosome proteome.
13 Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury*
14 Discriminatory Ability of Hypervariable Variable Number Tandem Repeat Loci in Population-based Analysis of Mycobacterium tuberculosis Strains, London, UK
15 Frequencies of Region of Difference-1 antigen-specific but 1 not PPD-specific IFN-γ-secreting T cells correlate with presence of tuberculosis disease but do not distinguish recent from remote infection
16 Controle da tuberculose no Brasil: dificuldades na implantação do programa
17 Classification of Mycobacterium Tuberculosis in Images of ZN-Stained Sputum Smears
18 Mycobacterium Tuberculosis: Assessing Your Laboratory
19 Role of interferon-gamma release assays in healthcare workers
20 BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as Q1 detected by gamma interferon release assay
21 Variation in T-SPOT.TB spot interpretation between independent observers of different laboratories
22 Positive Conversion of Tuberculin Skin Test and Performance of Interferon Release Assay to Detect Hidden Tuberculosis Infection During Anti-Tumor
23 Clinical utility of the QuantiFERON-TB Gold In-Tube test for the diagnosis of active pulmonary tuberculosis
24 Prevalence and Risk Factors for Tuberculosis Infection among Hospital Workers in Hanoi, Viet Nam
25 Evaluation of Interferon-Gamma Release Assays in the Diagnosis of Recent Tuberculosis Infection in Health Care Workers
26 Inappropriate gamma interferon testing: A review of practice in the west of Scotland
27 T-cell-based diagnosis of tuberculosis infection in children in Lithuania: a country of high incidence despite a high coverage with bacille Calmette-Guerin vaccination
28 A statistical method was used for the meta-analysis of tests for latent TB in the absence of a gold standard, combining random-effect and latent-class methods to estimate test accuracy
29 Diagnostic Accuracy of a Urine Lipoarabinomannan Test for Tuberculosis in Hospitalized Patients in a High HIV Prevalence Setting
30 "Evaluating diagnostics: Introducing evidence-based measures to an unregulated world"
31 A fast method for the identification of Mycobacterium tuberculosis in sputum and cultures based on thermally assisted hydrolysis and methylation followed by gas chromatography–mass spectrometry
32 QuantiFERON TB-2G test for patients with active tuberculosis stratified by age groups
33 Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany
34 Ultrasensitive Detection of Bacteria Using Core–Shell Nanoparticles and an NMR-Filter System**
35 TB diagnostic tests: how do we figure out their costs?
36 Rapid detection of resistant tuberculosis by nitrate reductase assay performed in three settings in Brazil
37 Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-c release assay vs. tuberculin skin test
38 Novel method for sputum induction using the Lung Flute in patients with suspected pulmonary tuberculosisresp_1584 1..4
39 Targeted screening and treatment for latent tuberculosis infection using QuantiFERON®-TB Gold is cost-effective in Mexico
40 Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
41 Light-emitting diode technologies for TB diagnosis: what is on the market?
42 Within-Subject Variability and Boosting of T-Cell Interferon-g Responses after Tuberculin Skin Testing
43 T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India
44 Systematic Review: T-Cell–based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update
45 T-cell interferon-g release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings
46 Evidence-Based Tuberculosis Diagnosis
47 New Diagnostics for Latent and Active Tuberculosis: State of the Art and Future Prospects
48 A Pilot Study of Short-Duration Sputum Pretreatment Procedures for Optimizing Smear Microscopy for Tuberculosis
49 Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study
50 Immunogenicity of Novel DosR Regulon-Encoded Candidate Antigens of Mycobacterium tuberculosis in Three High-Burden Populations in Africa
51 Use of a T Cell Interferon-g Release Assay to Evaluate Tuberculosis Risk in Newly Qualified Physicians in Singapore Healthcare Institutions
52 hole-Blood Interferon- Release Assay for the Diagnosis of Mycobacterium tuberculosis Infection in Children Correlates With Age and Immune Status
53 Tuberculosis in Liver Transplant Recipients: A Systematic Review and Meta-Analysis of Individual Patient Data
54 Mycobacterium tuberculosis Infection in Immunocompromised Hosts: A Diagnostic Challenge
55 CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South India.
56 Molecular detection, identi¢cationand drug resistance detection in Mycobacteriumtuberculosis
57 Impaired detection of M. tuberculosis immunity upon high levels of immunosuppressive drugs
58 Clusters of Multidrug-Resistant Mycobacterium tuberculosis Cases, Europe
59 Possible Outbreak of Streptomycin-Resistant Mycobacterium tuberculosis Beijing in Benin
60 Evidence-Based Tuberculosis Diagnosis
61 Performance of Purified Antigens for Serodiagnosis of Pulmonary Tuberculosis: a Meta-Analysis
62 Lessons in integration - operations research in Indian leprosy NGO
63 Developing operational research capacity in hospital tuberculosis control officers in Malawi
64 Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6
65 Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41
66 Capacity building for international tuberculosis control through operations research training
67 Change In Challenging Times: A Plan For Extending And Improving Health Coverage
68 Does DOTS work in populations with drug-resistant tuberculosis?
69 Human resources for control of tuberculosis and HIV-associated tuberculosis
70 The Magic Bullets And Tuberculosis Drug Targets
 

bottom

Validation: XHTML and CSS